162 related articles for article (PubMed ID: 1107227)
1. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
[TBL] [Abstract][Full Text] [Related]
2. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of parenteral and oral typhoid vaccination in mice challenged with a Salmonella typhi-Salmonella typhimurium hybrid.
Diena BB; Ryan A; Wallace R; Johnson EM; Baron LS; Ashton FE
Infect Immun; 1977 Mar; 15(3):997-8. PubMed ID: 67085
[TBL] [Abstract][Full Text] [Related]
5. Role of typhoid antigens in protection and pathogenicity for mice.
Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
[TBL] [Abstract][Full Text] [Related]
6. Mouse protective capabilities of Escherichia coli hybrids expressing Salmonella typhi antigens.
Diena BB; Lior H; Ryan A; Krol P; Johnson EM; Baron LS
Infect Immun; 1979 Apr; 24(1):90-3. PubMed ID: 378849
[TBL] [Abstract][Full Text] [Related]
7. Chemically-modified crude endotoxins as possible typhoid vaccines.
Pistole TG; Marcus S
Immunol Commun; 1973; 2(1):43-56. PubMed ID: 4609894
[No Abstract] [Full Text] [Related]
8. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal mouse virulence of Salmonella typhimurium hybrids expressing somatic antigen 9.
Johnson EM; Snellings NJ; Life CA; Baron LS
Infect Immun; 1974 Sep; 10(3):669-71. PubMed ID: 4609907
[TBL] [Abstract][Full Text] [Related]
10. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
11. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.
TULLY JG; CURRIE JA
J Bacteriol; 1962 Oct; 84(4):747-53. PubMed ID: 13994748
[TBL] [Abstract][Full Text] [Related]
12. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
[TBL] [Abstract][Full Text] [Related]
13. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
Wong KH; Feeley JC; Northrup RS; Forlines ME
Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
[TBL] [Abstract][Full Text] [Related]
14. Purified Vi antigens as possible typhoid vaccines.
Pistole TG; Marcus S
Immunol Commun; 1974; 3(3):227-38. PubMed ID: 4606971
[No Abstract] [Full Text] [Related]
15. [Use of hybrid strains of S, typhi and S. typhimurium for characterizing the biological activity of individual Salmonella antigens by the alternative recording of the experimental results].
Levina LA; Zaĭdner IG
Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):31-6. PubMed ID: 335742
[TBL] [Abstract][Full Text] [Related]
16. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
Kheĭfets LB; Stanislavskiĭ ES; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
[No Abstract] [Full Text] [Related]
17. [Effectiveness of the vaccine of Vi-antigen of Salmonella typhosa in children and adolescents].
D'iachenko PN; Dzhumaliev ND; Koshotov T; Zhoroev Zh
Zdravookhr Kirg; 1975; (5):49-53. PubMed ID: 1943
[No Abstract] [Full Text] [Related]
18. Effect of typhoid O antigen (endotoxin) on the virulence of an O-deficient variant of Salmonella typhosa.
GAINES S; TULLY JG
Am J Hyg; 1961 Mar; 73():224-30. PubMed ID: 13702956
[No Abstract] [Full Text] [Related]
19. [Immunobiological aspects of the typhoid bacteria carrier state (a review of the literature)].
Bilibin AF; Khundanov LL
Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):9-17. PubMed ID: 4615523
[No Abstract] [Full Text] [Related]
20. Vaccination against typhoid fever with a live oral vaccine.
Germanier R
Dev Biol Stand; 1976; 33():85-8. PubMed ID: 782975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
